BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 17316694)

  • 21. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
    Atamna H; Frey WH
    Mitochondrion; 2007 Sep; 7(5):297-310. PubMed ID: 17625988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal fluid deficiency of melatonin.
    Maurizi CP
    Med Hypotheses; 2001 Aug; 57(2):156-60. PubMed ID: 11461164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modelling of calcium dynamics in brain energy metabolism and Alzheimer's disease.
    Tiveci S; Akin A; Cakir T; Saybaşili H; Ulgen K
    Comput Biol Chem; 2005 Apr; 29(2):151-62. PubMed ID: 15833443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin.
    Moreira PI
    J Alzheimers Dis; 2012; 30 Suppl 2():S199-215. PubMed ID: 22269163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of chronic brain hypoperfusion in the pathogenesis of Alzheimer's disease--facts and hypotheses].
    Zádori D; Datki Z; Penke B
    Ideggyogy Sz; 2007 Nov; 60(11-12):428-37. PubMed ID: 18198789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer' s disease, oxidative stress and gammahydroxybutyrate.
    Mamelak M
    Neurobiol Aging; 2007 Sep; 28(9):1340-60. PubMed ID: 16837107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases.
    Trushina E; McMurray CT
    Neuroscience; 2007 Apr; 145(4):1233-48. PubMed ID: 17303344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain.
    Abolhassani N; Leon J; Sheng Z; Oka S; Hamasaki H; Iwaki T; Nakabeppu Y
    Mech Ageing Dev; 2017 Jan; 161(Pt A):95-104. PubMed ID: 27233446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach.
    Sultana R; Poon HF; Cai J; Pierce WM; Merchant M; Klein JB; Markesbery WR; Butterfield DA
    Neurobiol Dis; 2006 Apr; 22(1):76-87. PubMed ID: 16378731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation.
    Correia SC; Santos RX; Carvalho C; Cardoso S; Candeias E; Santos MS; Oliveira CR; Moreira PI
    Brain Res; 2012 Mar; 1441():64-78. PubMed ID: 22290178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease.
    Onyango IG; Khan SM
    Curr Alzheimer Res; 2006 Sep; 3(4):339-49. PubMed ID: 17017864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical exercise as a possible strategy for brain protection: evidence from mitochondrial-mediated mechanisms.
    Marques-Aleixo I; Oliveira PJ; Moreira PI; Magalhães J; Ascensão A
    Prog Neurobiol; 2012 Nov; 99(2):149-62. PubMed ID: 22940590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease.
    Aliev G; Smith MA; de la Torre JC; Perry G
    Mitochondrion; 2004 Sep; 4(5-6):649-63. PubMed ID: 16120422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.
    Hauptmann S; Scherping I; Dröse S; Brandt U; Schulz KL; Jendrach M; Leuner K; Eckert A; Müller WE
    Neurobiol Aging; 2009 Oct; 30(10):1574-86. PubMed ID: 18295378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral insulin and brain structure in early Alzheimer disease.
    Burns JM; Donnelly JE; Anderson HS; Mayo MS; Spencer-Gardner L; Thomas G; Cronk BB; Haddad Z; Klima D; Hansen D; Brooks WM
    Neurology; 2007 Sep; 69(11):1094-104. PubMed ID: 17846409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sporadic Alzheimer's disease: the starving brain.
    Mamelak M
    J Alzheimers Dis; 2012; 31(3):459-74. PubMed ID: 22571985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial damage modulates alternative splicing in neuronal cells: implications for neurodegeneration.
    Maracchioni A; Totaro A; Angelini DF; Di Penta A; Bernardi G; Carrì MT; Achsel T
    J Neurochem; 2007 Jan; 100(1):142-53. PubMed ID: 17064354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The killing of neurons by beta-amyloid peptides, prions, and pro-inflammatory cytokines.
    Chiarini A; Dal Pra I; Whitfield JF; Armato U
    Ital J Anat Embryol; 2006; 111(4):221-46. PubMed ID: 17385278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Edaravone protects against MPP+ -induced cytotoxicity in rat primary cultured astrocytes via inhibition of mitochondrial apoptotic pathway.
    Chen H; Wang S; Ding JH; Hu G
    J Neurochem; 2008 Sep; 106(6):2345-52. PubMed ID: 18643790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.